Is Arcus Biosciences, Inc. RCUS stock Halal to invest in?

Yes, as of September 2026, Arcus Biosciences, Inc. stock (RCUS) is classified as a Shariah compliant stock. Tabadulat applies AAOIFI Shariah Standard No. 21, issued by the Accounting and Auditing Organization for Islamic Financial Institutions, screening non-permissible income first and then the two interest-based ratios and the capital structure. On the latest data, Arcus Biosciences, Inc. passes on every count: non-permissible income under 5% of revenue, interest-bearing debt and investments each under 30% of market capitalisation, and no preference share issue. The stock's current purification factor is 100%. Compliance is reassessed every month as updated screening data arrives, and a stock's status can change when new financial reports are released. You can always check the current status of Arcus Biosciences, Inc. and explore other Shariah compliant stocks in the Tabadulat app.

How often is Arcus Biosciences, Inc. RCUS reviewed for Shariah compliance?

Tabadulat reviews Arcus Biosciences, Inc. RCUS for Shariah compliance every month. Each review applies the AAOIFI Shariah Standard No. 21 methodology, screening the company's business activities, non-permissible income, interest-bearing investments, interest-bearing debt, and preference shares, against the company's latest available financial data. The process operates under the direct supervision of Tabadulat's dedicated Shariah Supervisory Board of Islamic finance scholars. Because compliance depends on financial ratios that move with market capitalisation and reported results, a stock's status can change from one review to the next. Monthly screening ensures the status shown for Arcus Biosciences, Inc. reflects current financial data rather than an outdated assessment, and Tabadulat app users are notified if a holding in their portfolio becomes non-compliant.

Does Arcus Biosciences, Inc. RCUS pass the AAOIFI Non Permissible Income criteria?

Yes, as of September 2026, Arcus Biosciences, Inc. stock (RCUS) passes the AAOIFI non-permissible income screen. Under AAOIFI Shariah Standard No. 21, income from impermissible sources (such as interest or Riba, conventional financial services, alcohol, gambling, or tobacco) must remain below 5% of a company's total revenue. Arcus Biosciences, Inc.'s income from non-permissible sources is currently within this 5% threshold. Even permissible levels of incidental impure income should still be purified: investors donate the corresponding share of dividends to charity, as reflected in the stock's purification factor. This screen is reassessed monthly using the company's latest financial disclosures.

Does Arcus Biosciences, Inc. RCUS pass the AAOIFI Interest Bearing Investments criteria?

Yes, as of September 2026, Arcus Biosciences, Inc. stock (RCUS) passes the AAOIFI interest-bearing investments screen. Each month Tabadulat compares Arcus Biosciences, Inc.'s holdings in interest-earning instruments, such as conventional deposits, bonds and treasury bills, against AAOIFI's 30% market capitalisation cap. The current screening shows the company inside the limit. Because the ratio is measured against market capitalisation, it can move with the share price as well as the balance sheet, which is why Tabadulat rescreens the stock every month.

Does Arcus Biosciences, Inc. RCUS pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of September 2026, Arcus Biosciences, Inc. stock (RCUS) passes the AAOIFI interest-bearing debt screen. AAOIFI tolerates some conventional borrowing but draws the line at 30% of market capitalisation. On the latest data, Arcus Biosciences, Inc.'s interest-bearing debt stays below the line. Because market capitalisation changes daily, a company's debt ratio can drift toward or away from the limit even without new borrowing, which is why this screen is reassessed every month.

What is the dividend purification factor for Arcus Biosciences, Inc. RCUS stock?

The dividend purification factor for Arcus Biosciences, Inc. (RCUS) stands at 100% in the September 2026 screening. In plain terms, 100% of a RCUS dividend is retained, and the remainder reflects incidental non-permissible income, typically interest on corporate cash, which Halal investors donate to charity (Tazkiyah). AAOIFI methodology asks for purification even on fully compliant stocks. The factor is recalculated with each monthly screening as new financial data arrives, and the Tabadulat app can help you calculate and track purification across your whole portfolio.

Does Arcus Biosciences, Inc. RCUS pass the AAOIFI Preference Share screen?

Yes, as of September 2026, Arcus Biosciences, Inc. stock (RCUS) passes the AAOIFI preference share screen. AAOIFI Shariah Standard No. 21 prohibits investing in preference shares because they grant holders guaranteed or priority rights to dividends and capital ahead of ordinary shareholders, a structure that conflicts with the Shariah principle that investors should share profit and loss in proportion to their ownership. Arcus Biosciences, Inc. has no impermissible preference share structure affecting its ordinary shares, so the stock is compliant on this criterion. Like all AAOIFI screens, this is verified in each monthly review.

Invest Halal, Anytime, Anywhere

Download the Tabadulat app and start building your Shariah-compliant portfolio in minutes.

English

العربية

Is Arcus Biosciences (RCUS) stock Halal?

NYSE

Shariah-Compliant

Not Shariah

September 2026 AAOIFI screening result for Arcus Biosciences, Inc. (RCUS): non-permissible income, pass. Interest-bearing investments, pass. Interest-bearing debt, pass. Preference shares, pass. Dividend purification factor: 100%. Re-screened monthly against AAOIFI Shariah Standard No. 21.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

627

Website:

https://www.arcusbio.com

Market cap:

$3.8B

P/E ratio:

Dividend yield:

52-week range:

$10.72 - $31.73

Data as of:

3 September 2026

Screening history:

September 2026: PASS

Arcus Biosciences is a biopharmaceutical company dedicated to developing innovative cancer therapies. Focusing primarily on immuno-oncology, the company aims to harness the body's own immune system to target and eliminate cancer cells. Arcus Biosciences' pipeline includes a variety of monoclonal antibodies, small molecules, and combination therapies that address different aspects of cancer's complex biology. One of its core strategies is to develop next-generation treatments that can potentially improve upon existing therapies, enhancing efficacy while minimizing side effects. Before any of that matters to a Muslim investor, one question comes first: is Arcus Biosciences stock Halal?

Is Arcus Biosciences Shariah compliant?

The Shariah case on a technology company like Arcus Biosciences is rarely about the product. What AAOIFI Shariah Standard No. 21 examines is the money around the product: cash parked in instruments that earn Riba, borrowing measured against a market capitalisation that moves daily, and any incidental income from sources Islam prohibits, which must stay below 5% of revenue.

Does Arcus Biosciences pass the business activity test?

Yes. In the September 2026 screening Arcus Biosciences holds an overall PASS, which a stock only earns when its core business clears the activity screen. The watch item for technology names is incidental: cash returns and platform content can carry impermissible elements, which AAOIFI tolerates only below the thresholds.

Is Arcus Biosciences' income Halal?

Yes, within AAOIFI's tolerance. Arcus Biosciences' income from non-permissible sources stays below 5% of revenue in the September 2026 screening, and the small impure portion is handled through purification: the factor of 100% tells holders of RCUS what share of each dividend to keep and what remainder to donate to charity.

Does Arcus Biosciences meet AAOIFI's debt and investment ratio requirements?

Yes. Both caps hold this month: interest bearing investments and interest bearing debt each stay below 30% of market capitalisation. Because the caps move with the share price, our Shariah Supervisory Board has RCUS re-screened every month, and the result above always shows the latest verdict.

Tabadulat is an ADGM regulated brokerage whose license covers Shari'a Compliant Regulated Activities, as the FSRA permission names them. New to the terminology? Gharar and Maysir, Sukuk, Zakat and purification are all explained in plain English.

New to the four screens? Read Why a Halal Stock Screener Matters for Halal Investing

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Open your account.

Create your Tabadulat account in minutes: enter your details, complete identity verification, and add funds by secure transfer in multiple currencies. You're ready to start investing in Halal stocks the same day.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.